Blend Labs (NYSE: BLND) exits Title365 title insurance business

Rhea-AI Filing Summary

Blend Labs, Inc. has completed a strategic transaction affecting its title insurance operations. On March 1, 2026, the company completed the sale of substantially all the assets and liabilities of Title365 Company, which represented Blend’s title insurance business, to Covius Services, LLC. This move means Blend is exiting ownership of its Title365 title insurance unit and transferring its related assets and obligations to Covius.

Insights

Fintech and Business Strategy Analyst

Blend divests its Title365 title insurance business to Covius.

Blend Labs, Inc. completed the sale of substantially all assets and liabilities of Title365 Company, its title insurance business, to Covius Services, LLC on March 1, 2026. This indicates a clear strategic step away from directly operating that title insurance unit.

The transaction removes both the assets and related liabilities of Title365 from Blend’s structure. Exact financial terms and impact are not provided in the excerpt, so the magnitude of balance sheet or earnings change cannot be assessed here.

Subsequent company filings may provide more detail on how this divestiture affects Blend’s revenue mix, expenses, and strategic focus following the transfer of the Title365 title insurance business.

FALSE000185574700018557472026-03-012026-03-01

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): March 1, 2026

Blend Labs, Inc.

(Exact name of Registrant, as specified in its charter)

Delaware

001-40599

45-5211045

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification Number)

7250 Redwood Blvd., Suite 300

Novato, California 94945

(Address of principal executive offices, including zip code)

(650) 550-4810

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, par value of $0.00001 per share

BLND

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01    Regulation FD Disclosure

On March 1, 2026, Blend Labs, Inc. (“Blend”) completed the sale of substantially all the assets and liabilities of Title365 Company, which constituted Blend’s title insurance business, to Covius Services, LLC.

The information in Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Blend Labs, Inc.
Date: March 2, 2026
			By:			/s/ Jason Ream
			Name:			Jason Ream
			Title:			Head of Finance and Administration (Principal Financial Officer)

FAQ

What business did Blend Labs (BLND) sell to Covius Services, LLC?

Blend Labs sold substantially all the assets and liabilities of Title365 Company, which constituted its title insurance business. This divests Blend of that specific title insurance unit and transfers its related operations and obligations to Covius Services, LLC.

When did Blend Labs (BLND) complete the sale of Title365 Company?

Blend Labs completed the sale of substantially all the assets and liabilities of Title365 Company on March 1, 2026. This date marks the effective completion of the transaction involving its title insurance business and the transfer to Covius Services, LLC.

How is the Blend Labs (BLND) Title365 sale disclosed under SEC rules?

The sale is disclosed under Item 7.01 Regulation FD Disclosure. The information is expressly stated as not deemed “filed” for purposes of Section 18 of the Exchange Act, limiting certain liability and incorporation-by-reference effects under federal securities laws.

What part of Blend Labs’ operations did Title365 Company represent?

Title365 Company constituted Blend Labs’ title insurance business. By selling substantially all of Title365’s assets and liabilities, Blend is exiting that specific title insurance operation and transferring both its assets and related obligations to Covius Services, LLC.

Does Blend Labs’ 8-K say the Title365 information is incorporated into other filings?

The disclosure states it is not deemed incorporated by reference into any Securities Act or Exchange Act filing, unless specifically referenced. This language clarifies the regulatory status of the information for other Blend Labs registration statements or periodic reports.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.7 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 22.0 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.7 KB